PMID

Data

Article Title

Organization

Discovery and dimeric approach of novel Natriuretic Peptide Receptor A (NPR-A) agonists.

Asubio Pharma

Intramolecular azo-bridge as a cystine disulfide bond surrogate: Somatostatin-14 and brain natriuretic peptide (BNP) analogs.

The Weizmann Institute of Science

Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation.

China Pharmaceutical University

Structure-activity relationships for mini atrial natriuretic peptide by proline-scanning mutagenesis and shortening of peptide backbone.

Institute For Bioorganic Research

The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. Part 1.

Astrazeneca Pharmaceuticals

Discovery and in vivo effects of novel human natriuretic peptide receptor A (NPR-A) agonists with improved activity for rat NPR-A.

Asubio Pharma

Discovery and SAR of a novel series of Natriuretic Peptide Receptor-A (NPR-A) agonists.

Asubio Pharma

A potent and selective natriuretic peptide receptor-3 blocker 11-mer peptide created by hybridization of musclin and atrial natriuretic peptide.

Takeda Pharmaceutical